Abbott Labs Files 8-K on Officer Changes & Filings
Ticker: ABT · Form: 8-K · Filed: Dec 12, 2025 · CIK: 1800
| Field | Detail |
|---|---|
| Company | Abbott Laboratories (ABT) |
| Form Type | 8-K |
| Filed Date | Dec 12, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, officer-changes, filing
Related Tickers: ABT
TL;DR
ABT filed an 8-K detailing officer changes and corporate updates.
AI Summary
Abbott Laboratories filed an 8-K on December 12, 2025, reporting on the departure of directors or certain officers, the election of directors, the appointment of certain officers, and compensatory arrangements. The filing also covers amendments to articles of incorporation or bylaws, changes in fiscal year, and financial statements and exhibits.
Why It Matters
This filing provides updates on key personnel changes and corporate governance at Abbott Laboratories, which could impact investor confidence and strategic direction.
Risk Assessment
Risk Level: low — The filing is routine and reports on standard corporate events like director changes and officer appointments, with no immediate financial distress indicated.
Key Players & Entities
- Abbott Laboratories (company) — Registrant
- December 12, 2025 (date) — Date of earliest event reported
FAQ
What specific officer positions were affected by the changes reported in this 8-K?
The filing indicates "Departure of Directors or Certain Officers" and "Appointment of Certain Officers," but does not specify the exact positions in the provided text.
Were there any amendments to Abbott Laboratories' articles of incorporation or bylaws?
Yes, the filing explicitly lists "Amendments to Articles of Incorporation or Bylaws" as an item of information being reported.
Does this filing include any new financial statements?
Yes, the filing states that "Financial Statements and Exhibits" are being filed as part of this report.
What is the date of the earliest event reported in this 8-K?
The date of the earliest event reported is December 12, 2025.
What is the Standard Industrial Classification (SIC) code for Abbott Laboratories?
The SIC code for Abbott Laboratories is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 486 words · 2 min read · ~2 pages · Grade level 11.7 · Accepted 2025-12-12 16:10:48
Filing Documents
- tm2533113d1_8k.htm (8-K) — 29KB
- tm2533113d1_ex99-1.htm (EX-99.1) — 197KB
- tm2533113d1_ex99-1img001.jpg (GRAPHIC) — 1KB
- 0001104659-25-120657.txt ( ) — 485KB
- abt-20251212.xsd (EX-101.SCH) — 3KB
- abt-20251212_def.xml (EX-101.DEF) — 28KB
- abt-20251212_lab.xml (EX-101.LAB) — 37KB
- abt-20251212_pre.xml (EX-101.PRE) — 26KB
- tm2533113d1_8k_htm.xml (XML) — 6KB
03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. On December 12, 2025, Abbott's Board of Directors amended the first sentence of Article III, Section 2 of Abbott's by-laws to provide that Abbott's Board of Directors shall consist of thirteen persons, effective as of December 12, 2025. Abbott's by-laws previously provided that the Board of Directors consisted of twelve persons.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. Exhibit No. Exhibit 99.1 By-Laws of Abbott Laboratories, as amended and restated, effective December 12, 2025. 104 Cover Page Interactive Data File (the cover page XBRL tags are embedded in the Inline XBRL document). SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ABBOTT LABORATORIES Date: December 12, 2025 By: /s/ Philip P. Boudreau Philip P. Boudreau Executive Vice President, Finance and Chief Financial Officer